Genedata - The Case Centre

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Case

Reference no. IMD-1-0240

Subject category: Finance, Accounting and Control

Authors: Benoit Leleux (International Institute for Management Development (IMD)); Atul Pahwa (International Institute for Management Development (IMD))

Published by: International Institute for Management Development (IMD)

Originally published in: 2005

Version: 12.06.2006

Length: 7 pages

Data source: Field research

Topics: Biotechnology; Valuation; Start-up; Entrepreneurship; Pharmaceuticals; Genomics; Software; Development stage enterprise

Share a link: https://casecent.re/p/69322

| No reviews for this item

This product has not been used yet

View our pricing guide or login to see prices.

Abstract

This is part of a case series. Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyse and structure the next financing round. Venture Valuation, under a tight investment time-frame, has to customise the evaluation process, using both quantitative and qualitative data, to meet the customers needs. The case outlines Genedata's background, its product portfolio, competitive positioning, and issues that it will need to deal with in the near future.

Location:

Basel, Switzerland

Industry:

Bio-technology, pharmaceutical

Size:

Start-up

Other setting(s):

2000-2005